Ownership
Private
Stage
Other
Preclinical
Phase 1
Phase 2
Phase 3
Approved

iLAB General Information

iLAB is an established provider of software quality assurance and testing solutions, with a significant focus on healthcare and pharmaceutical clients. The company helps hospitals, healthcare facilities, and pharmaceutical businesses implement, test, and optimize digital systems such as telehealth platforms, remote patient monitoring tools, billing systems, contact tracing applications (e.g., for COVID-19), and more. Their services aim to improve technology integration in healthcare settings by ensuring reliability, security, compliance (including standards like HL7), and user satisfaction[1][6].

Contact Information

Primary Industry
Biomedical IT and Biomedical Data Platforms
Corporate Office
,
Unknown

Drug Pipeline

No pipeline data available

For full access to iLAB's pipeline data

Book a demo

Key Partnerships

Various healthcare institutions/hospitals

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

iLAB Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view iLAB's complete valuation and funding history, request access »

iLAB Financial Metrics